4 Amendments of Jean-François JALKH related to 2016/2169(DEC)
Amendment 3 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Emphasises, in that connection, that the significant share of its budget drawn from private sources raises the question of the independence of the Agency vis-à-vis the pharmaceutical industry;
Amendment 8 #
Draft opinion
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Emphasises that Brexit constitutes a new challenge for the Agency, which will have to cope with a change of seat that will necessitate many decisions concerning the management of its staff;
Amendment 18 #
Draft opinion
Paragraph 8
Paragraph 8
8. Reiterates the important role of the Agency in protecting and promoting public and animal health by assessing and supervising medicines for human or veterinary use, and emphasises, in that connection, that the Agency must pay close attention to the findings of independent and reliable scientific analyses and that a failure to do so may give rise to serious risks to public health in the EU;
Amendment 21 #
Draft opinion
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Emphasises, in that connection, that the failure to take account of independent scientific analyses seems to have been glaring in the case of vaccines against the papilloma virus and their undesirable side effects;